Pharmaceutical company Strides Pharma Science shares rose over 11.5% to hit a 52-week high; Details

Strides Pharma Shares Hit 52-Week High As USFDA Tentative Nod To HIV Treatment Drug - News18

Strides Pharma Standalone June 2023 Net Sales at Rs 475.32 crore, up 12.32% Y-o-Y

Strides Pharma Consolidated June 2023 Net Sales at Rs 929.99 crore, down 1.07% Y-o-Y

The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.

Strides Pharma sinks after subsidiary plans to divest manufacturing plant

Stocks likely to see action on July 5 are PSU banks, BHEL, LTIMindtree, Aurobindo Pharma, Genus Power, Lodha, Samvardhana Motherson, IOC, Suzlon, Strides Pharma, Syngene International, Bandhan Bank

Stocks that will see action today (July 5)

Strides Pharma Science has agreed to sell the biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma to Syngene International for INR702 crore ($94m) in cash. Syngene will also invest up to INR100 crore to repurpose and revalidate the Bommasandra Industrial Area in Bengalu…

Strides sells arm’s manufacturing unit to Syngene International for Rs 702 crore

Sharekhan is bullish on Strides Pharma Sciences Ltd has recommended buy rating on the stock with a target price of Rs 450 in its research report dated June 01, 2023.

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

Business Standard | Stocks to watch today on May 25, 2023: AIA Engineering, eClerx, GSFC, Voda Idea, IEX, IFCI, Page Inds, SAIL, Strides Pharma, and Zee among prominent companies scheduled to announce Q4 results on Thursday.

Stocks to Watch today | May 25, 2023 | Business Standard: Nykaa, LIC, Adani Group, Hindalco, Nalco

Here are the estimates for March quarter earnings of major companies scheduled to be announced on Thursday.

Vodafone Idea, Zee, Infibeam Avenues, Strides Pharma, Emami Q4 Results Today: Here’s What To Expect

Stocks to watch before going into trade today.

Stocks To Watch: LIC, Vodafone Idea, Zee, Oil India, Strides Pharma, Emami, Adani Ports, Nykaa, Wipro

Strides Pharma Science and Orbicular Pharmaceutical Technologies Private Limited (Orbicular) will jointly develop, manufacture, and commercialise nasal sprays for global markets. The partnership will commercialise four nasal sprays with a combined global IQVIA market size in excess of $400 million.

Strides Pharma, Orbicular Pharmaceutical to develop nasal sprays for global markets

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech